931 related articles for article (PubMed ID: 32976952)
1. Major Depressive Disorder and gut microbiota - Association not causation. A scoping review.
Łoniewski I; Misera A; Skonieczna-Żydecka K; Kaczmarczyk M; Kaźmierczak-Siedlecka K; Misiak B; Marlicz W; Samochowiec J
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110111. PubMed ID: 32976952
[TBL] [Abstract][Full Text] [Related]
2. Targeting the endocannabinoid system with microbial interventions to improve gut integrity.
Jansma J; Brinkman F; van Hemert S; El Aidy S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110169. PubMed ID: 33186639
[TBL] [Abstract][Full Text] [Related]
3. The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol.
Karakula-Juchnowicz H; Rog J; Juchnowicz D; Łoniewski I; Skonieczna-Żydecka K; Krukow P; Futyma-Jedrzejewska M; Kaczmarczyk M
Nutr J; 2019 Aug; 18(1):50. PubMed ID: 31472678
[TBL] [Abstract][Full Text] [Related]
4. Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: a prospective case-control study.
Ciocan D; Cassard AM; Becquemont L; Verstuyft C; Voican CS; El Asmar K; Colle R; David D; Trabado S; Feve B; Chanson P; Perlemuter G; Corruble E
J Psychiatry Neurosci; 2021 May; 46(3):E358-E368. PubMed ID: 34008933
[TBL] [Abstract][Full Text] [Related]
5. Probiotics as an Adjuvant Therapy in Major Depressive Disorder.
Vlainić JV; Šuran J; Vlainić T; Vukorep AL
Curr Neuropharmacol; 2016; 14(8):952-958. PubMed ID: 27226112
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.
Zeng C; Yang P; Cao T; Gu Y; Li N; Zhang B; Xu P; Liu Y; Luo Z; Cai H
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110097. PubMed ID: 32916223
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Pathophysiology of Depressive Disorder.
Kunugi H
Ann Nutr Metab; 2021; 77 Suppl 2():11-20. PubMed ID: 34350881
[TBL] [Abstract][Full Text] [Related]
8. Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.
Bastiaanssen TFS; Cussotto S; Claesson MJ; Clarke G; Dinan TG; Cryan JF
Harv Rev Psychiatry; 2020; 28(1):26-39. PubMed ID: 31913980
[TBL] [Abstract][Full Text] [Related]
9. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
10. How Microbes Affect Depression: Underlying Mechanisms via the Gut-Brain Axis and the Modulating Role of Probiotics.
Suda K; Matsuda K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163104
[TBL] [Abstract][Full Text] [Related]
11. The Microbiota-Gut-Brain Axis in Psychiatric Disorders.
Góralczyk-Bińkowska A; Szmajda-Krygier D; Kozłowska E
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232548
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of Gut-microbiota-brain axis in depression and therapeutic implication.
Evrensel A; Tarhan KN
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110138. PubMed ID: 33075447
[TBL] [Abstract][Full Text] [Related]
13. Microbiome and substances of abuse.
Salavrakos M; Leclercq S; De Timary P; Dom G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110113. PubMed ID: 32971216
[TBL] [Abstract][Full Text] [Related]
14. Remodeling of microbiota gut-brain axis using psychobiotics in depression.
Palepu MSK; Dandekar MP
Eur J Pharmacol; 2022 Sep; 931():175171. PubMed ID: 35926568
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder.
Młynarska E; Gadzinowska J; Tokarek J; Forycka J; Szuman A; Franczyk B; Rysz J
Nutrients; 2022 May; 14(9):. PubMed ID: 35565888
[TBL] [Abstract][Full Text] [Related]
16. The Microbiota-Inflammasome Hypothesis of Major Depression.
Inserra A; Rogers GB; Licinio J; Wong ML
Bioessays; 2018 Sep; 40(9):e1800027. PubMed ID: 30004130
[TBL] [Abstract][Full Text] [Related]
17. Potential of Probiotics as an Adjunct for Patients with Major Depressive Disorder.
Cang W; Wu J; Ding R; Wang W; Li N; Shi H; Shi L; Lee Y; Wu R
Mol Nutr Food Res; 2022 May; 66(10):e2101057. PubMed ID: 35286767
[TBL] [Abstract][Full Text] [Related]
18. The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies.
Alli SR; Gorbovskaya I; Liu JCW; Kolla NJ; Brown L; Müller DJ
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562885
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-brain axis in depression: The role of neuroinflammation.
Carlessi AS; Borba LA; Zugno AI; Quevedo J; Réus GZ
Eur J Neurosci; 2021 Jan; 53(1):222-235. PubMed ID: 31785168
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder.
Wang Y; Zhou J; Ye J; Sun Z; He Y; Zhao Y; Ren S; Zhang G; Liu M; Zheng P; Wang G; Yang J
Microbiome; 2023 Aug; 11(1):195. PubMed ID: 37641148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
